sultry 发表于 2025-3-26 21:20:36

https://doi.org/10.1007/978-3-319-42792-8uctive stress, leading to cellular damage and dysregulation. Excessive reactive oxygen species (ROS) deteriorates vascular functions and promotes vascular diseases through multiple pathways. Recently, cyclophilin A (CyPA) has been shown to be secreted from vascular smooth muscle cells (VSMC) and to

rheumatism 发表于 2025-3-27 04:22:18

https://doi.org/10.1007/978-94-007-7696-8Application to prognosis; Biomarkers in disease; Cancer Research; Discovery of biomarkers; High throughp

退出可食用 发表于 2025-3-27 05:18:48

Springer Science+Business Media Dordrecht 2015

Hyperlipidemia 发表于 2025-3-27 11:47:37

High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validationredictions of the imminent breakthroughs in our understanding of human diseases and making predictive diagnostics easy, however, turned out to be largely over optimistic..We argue that this situation is not coincidental, but rather is caused by the statistical properties of the data collected. A typ

航海太平洋 发表于 2025-3-27 17:41:35

http://reply.papertrans.cn/39/3821/382077/382077_35.png

interpose 发表于 2025-3-27 19:32:05

http://reply.papertrans.cn/39/3821/382077/382077_36.png

Receive 发表于 2025-3-27 22:02:54

Toxicogenomic and Pharmacogenomic Biomarkers for Drug Discovery and Personalized Medicines of drug development may necessitate a return to seed compound screening, because toxicity is often inherent to the basic structure and is thus difficult to be eliminated by minor modification. An urgent need therefore exists for safety biomarkers that enable prediction of potential toxicity and pr

indifferent 发表于 2025-3-28 04:55:26

Glycome as Biomarkerslycans of glycoconjugates, glycomic approaches to discover novel biomarkers are just on the rise. Routinely used glycan biomarkers have been developed using traditional immunological techniques and monoclonal antibody technology. Recent progress in the development of analytical methodologies and str

可憎 发表于 2025-3-28 09:28:40

Flow Cytometry as Platform for Biomarker Discovery and Clinical Validationplantation, autoimmunity, tumor immunology, chemotherapy, etc.), making it highly useful not only in the discovery of new biomarkers but also in clinical validation and routine implementation. FC simultaneously provides information about the phenotypic and functional characteristics of cells and ena

florid 发表于 2025-3-28 13:22:37

http://reply.papertrans.cn/39/3821/382077/382077_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: General Methods in Biomarker Research and their Applications; Victor R. Preedy,Vinood B. Patel Reference work 2015 Springer Science+Busine